United States
IpiNovyx Bio, founded in 2021, is a promising startup in the Biopharma and Biotechnology sectors, with a specific focus on Health Care. The company is headquartered in the United States.
Embodying the slogan, "We are a drug platform focused on treating autoimmune and inflammatory diseases," IpiNovyx Bio is developing a series of highly selective, ultra-potent, small molecule therapeutics aimed at transforming the treatment of autoimmune and inflammatory disorders. This disruptive technology holds significant potential to redefine therapeutic approaches, offering new hope for patients.
The startup attracted a noteworthy $10.00M in seed investment on 01 October 2021, with backing from reputable investors such as Viva BioInnovator, Alexandria Venture Investments, Lilly Ventures, Opaleye Management, and Orange Grove Bio. This backing underscores the confidence in IpiNovyx Bio's innovative capabilities and its potential impact on the biopharmaceutical landscape.
